# AvKARE – FDA Inspection, Nov 2, 2022

Source: https://www.keypedia.com/records/fda_inspections/avkare/7809c462-6e0a-4dc6-ba39-e45b7bf29fa7
Source feed: FDA_Inspections

> FDA inspection 1187248 of AvKARE, November 02, 2022. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1187248
- Company Name: AvKARE
- Inspection Date: 2022-11-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1180553 - 2022-08-23
- FDA Inspection 1031035 - 2017-06-06
- FDA Inspection 883310 - 2014-06-09

Company: https://www.keypedia.com/companies/avkare/7412af8d-e223-4f5b-90f3-24a1cc0b3838

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c